P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Trial Profile

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Completed
Phase of Trial: Phase II

Latest Information Update: 25 May 2018

At a glance

  • Drugs P 03277 (Primary) ; Gadobenic acid
  • Indications CNS disorders
  • Focus Diagnostic use
  • Sponsors Guerbet
  • Most Recent Events

    • 24 Mar 2018 This trial has been completed in Belgium (End date: 2018-01-23).
    • 19 Mar 2018 Status changed from recruiting to completed.
    • 06 Mar 2018 This study has been completed in Hungary (end date of the trial : 2018-01-23 ) as per European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top